Volume 11, Number 6, June 2005

Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance Programs

John M. Stelling,*† Karin Travers,* Ronald N. Jones,‡§ Philip J. Turner,¶ Thomas F. O'Brien,*† and Stuart B. Levy*§
*Alliance for the Prudent Use of Antibiotics, Boston, Massachusetts, USA; †Brigham and Women's Hospital, Boston, Massachusetts, USA; ‡The Jones Group, North Liberty, Iowa, USA; §Tufts University, Boston, Massachusetts, USA; and ¶AstraZeneca, Macclesfield, Cheshire, United Kingdom

Figure 1. Comparison of MYSTIC and SENTRY rates of Escherichia coli nonsusceptibility rates in 2001 to antimicrobial drugs tested by both networks. Significant findings are indicated with an asterisk where the MYSTIC estimate is higher than the SENTRY result and with a plus sign when the SENTRY estimate is higher. Country codes are the official 3-letter codes designated by the International Organization for Standardization: BEL, Belgium; CAN, Canada; DEU, Germany; ESP, Spain; GBR, United Kingdom; GRC, Greece; ITA, Italy; SWE, Sweden; TUR, Turkey; and USA, United States.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed May 5, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention